Author:
Hartmann J T,Oechsle K,Quietzsch D,Wein A,Hofheinz R D,Honecker F,Nehls O,Köhne C-H,Käfer G,Kanz L,Bokemeyer C
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Ardalan B, Chua L, Tian EM, Reddy R, Sridhar K, Benedetto P, Richman S, Legaspi A, Waldman S, Morrell S, Morrell L, Feun L, Savaraj N, Livingstone A (1991) A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma. J Clin Oncol 9: 625–630
2. Becker K, Rinas U, Weidmann B, Heider A, Niederle N (1997) High-dose 5-fluourouracil/folinic acid plus mitomycin C in patients with refractory colorectal cancer. Proc Am Soc Clin Oncol 16: 283
3. Cascinu S, Graziano F, Cardarelli N, Marcellini M, Giordani P, Menichetti ET, Catalano G (1998) Phase II study of paclitaxel in pretreated advanced gastric cancer. Anticancer Drugs 9: 307–310
4. Chang HM, Jung KH, Kim TY, Kim WS, Yang HK, Lee KU, Choe KJ, Heo DS, Bang YJ, Kim NK (2002) A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer. Ann Oncol 13: 1779–1785
5. Chester JD, Dent JT, Wilson G, Ride E, Seymour MT (2000) Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer. Ann Oncol 11: 235–237
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献